Loading…
Hosted by Prof. Keenan Hartert · 🇺🇸 US · EN · 27 episodes
Established thought leaders with verified media credentials.
Welcome to For Whom the Cell Tolls! This cast explores the fascinating stories of Biology that I've encountered in my journey as a Biology Professor and lymphoma scientist at Minnesota State University and my previous experience at Mayo Clinic. Major themes to be explored include cancer, tumorigenesis, new therapy mechanisms, immunology, life/death, disease ecology, microbiology, and evolution, among others. I try to integrate philosophy, culture, and the arts alongside emerging Biology findings to share the stories of life that I have always loved. Enjoy!https://profkeenanhartert.weebly.com
Prof. Keenan Hartert hosts For Whom the Cell Tolls: Cancer Biology, a science show with 27 episodes published.
Controversy! The snappy title isn’t an insult either. It’s respect, paired with a call to action to recognize our new AI (LLM) passengers. Nothing more powerful exists within Biology than tumors, but that’s just me the c
Welcome to our most CONTROVERSIAL episode yet! We address “Turbo cancer” (idk what’s specifically meant by this still but I outline the likely/historical geneses behind these cases), inflammation issues, central dogma ba
Welcome to a special episode where I'm joined by 11 of my Minnesota State students as we close out our Cancer Biology lecture! We weave through discussions surrounding generational causes of cancer, potential next-genera
The basic answer is no. When faced with R-CHOP resistance, DLBCL patients now have the option to utilize genetically modified Chimeric Antigen Receptor T-cells (CAR-T) designed to hunt tumors. This episode investigates t
Hello! I’m recently returned from my annual ASH meeting where I see all of the latest advances in blood cancers. This specific facet was my favorite: small, insurgent populations of healthy B-cells portend better surviva
Welcome back! It's been a while. I'm excited to get going again with an episode on the emerging science of "ecotyping" the cells around tumors - the microenvironment. Ecology and Evolution of lymphoma tumors is only half
What do you think? Would the immensely powerful amount of data be a game-changer for medicine? Or does DNA sequencing miss too much of the picture to be worth the cost? This question is an example why we need leaders tha
Can your genome match you with a soulmate? Sort of, but we’d need more than just mammal genomes to know... I hope you enjoy, and collect your thoughts on the proposal at the end of the episode if you’re interested!
The Netflix series The One is based on a book with a similar premise: via genome sequencing, we can match you with your best possible partner. The show is a great watch, and the science is not too far outside the possibl
This episode covers how gene therapy may emerge as a critical tool for medicine as we seek to treat the previously untreatable. Can we ADD genes to specific cells to help humans overcome fated genetic ailments? Why has t
BONUS EPISODE - I collected the top 20 insights from my personal and professional colleagues that completed or are currently undertaking medical school or another healthcare program to share with my students. This episod
Join me and Gustavus Adolphus College colleague Katie Peterson to discuss our research, how we teach, our paths to becoming professors, and student questions! In this episode we address interdisciplinary connections betw
This episode covers the basics of how a cancer begins. Genetic mutations can often knock out genes responsible for keeping an eye on how many cell divisions are allowed. Once these are out of the way, aggressive growth g
Chimeric Antigen Receptor T-cells (CAR-T) represent one of the most profound and exciting advances in modern medicine and science. Many lymphoma patients fail therapy after therapy with little recourse. CAR-T aimed to st
We live in an age where social media provides a platform for everything - good and bad. I wanted to summarize how ideas can be spread, weaponized, and distorted, much like a disease. We also briefly go over the differenc
Today’s episode details my research area: B-cells and the resulting lymphomas. The journey of a B-cell is violent and chaotic. To produce the best possible antibody protein against pathogen, the body employs an all-or-no
This is an exciting and quick episode that mainly covers the findings of a recent Daniel D. Carvalho paper in Nature Reviews called “Epigenetic therapy in immune oncology” where the authors elaborate on new mechanisms of
Domestication is a very interesting process and was first performed millions of years ago. The relationships between humans and dogs is of particular interest, as are the genetic and developmental changes that make them
Everything you’ve heard about CRISPR is likely closer to the truth than not. The possibilities are exiting, and the possibilities are terrifying. This episode dives into the logic and ethics behind CRISPR-Cas9’s DNA-chan
Today’s episode is the first one that is primarily driven by literature and philosophy, namely borrowing themes explored in Frankenstein and Paradise Lost. Victor Frankenstein’s fraught relationship with his creature is
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
For Whom the Cell Tolls: Cancer Biology has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
For Whom the Cell Tolls: Cancer Biology is hosted by Prof. Keenan Hartert. The show is categorised under science and has published 27 episodes.
For Whom the Cell Tolls: Cancer Biology has published 27 episodes.
For Whom the Cell Tolls: Cancer Biology regularly covers science. It sits in the science category.
For Whom the Cell Tolls: Cancer Biology is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
For Whom the Cell Tolls: Cancer Biology hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of For Whom the Cell Tolls: Cancer Biology average 28 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates For Whom the Cell Tolls: Cancer Biology's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 6 days ago.